Home/Filings/4/0001127602-23-012229
4//SEC Filing

Havanec Laurie P. 4

Accession 0001127602-23-012229

CIK 0000064803other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:29 PM ET

Size

9.1 KB

Accession

0001127602-23-012229

Insider Transaction Report

Form 4
Period: 2023-04-01
Havanec Laurie P.
EVP and Chief People Officer
Transactions
  • Award

    Stock Option

    2023-04-01$74.31/sh+51,959$3,861,07351,959 total
    Exercise: $74.31From: 2024-04-01Exp: 2033-04-01Common Stock (51,959 underlying)
Holdings
  • Common Stock (Restricted)

    14,678
  • Stock Option

    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01Common Stock (21,829 underlying)
    21,829
  • Common Stock

    20,386
  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01Common Stock (27,643 underlying)
    27,643
Footnotes (3)
  • [F1]Option became exercisable in four equal installments, commencing 4/1/2022.
  • [F2]Option became exercisable in four equal installments, commencing 4/1/2023.
  • [F3]Option becomes exercisable in four equal installments, commencing 4/1/2024.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001807757

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:29 PM ET
Size
9.1 KB